Contact & FAQs
Werewolf Therapeutics’ headquarters are located at 303 Wyman Street, Suite 300, Waltham, MA 02451.
The Company was founded in 2017.
The Company is incorporated in Delaware.
Werewolf Therapeutics completed its IPO on April 29, 2021.
The Company’s fiscal year ends December 31st.
The Company’s common stock is listed on the NASDAQ Market under the symbol “HOWL”.
The transfer agent and registrar for the common stock of Werewolf Therapeutics’ stock is:
Computershare Trust Company, N.A.
P.O. Box 505000 (mail)
Louisville KY 40233-5000
462 South 4th Street, Suite 1600 (overnight delivery)
Louisville KY 40202
1.800.736.3001, option 1 (U.S. toll-free)
1.781.575.3100, option 1 (non-U.S.)
web.queries@computershare.com
www.computershare.com
For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A., P.O. Box 505000, Louisville KY 40233-5000 (mail) or 462 South 4th Street, Suite 1600, Louisville KY 40202 (overnight delivery).
To transfer stock or replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A.
The auditor for Werewolf Therapeutics is Ernst & Young LLP located in Boston, MA.
Legal counsel for Werewolf Therapeutics is Sidley Austin LLP located in Boston, MA.